I. B. R. Duncan - Concepedia

Author

I. B. R. Duncan

Also Known As

Angela Esterhammer, Caroline McCracken-Flesher, I B DUNCAN, I B Duncan, I Duncan, I. B. DUNCAN, I. B. Duncan, I. B. R. Duncan, I. Duncan, I.B. Duncan

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Roche (United Kingdom)University of Toronto Roche (Switzerland)Medical Research Council Istituto Superiore di Sanità

About

I. B. R. Duncan is an author at Roche (United Kingdom) specializing in medicine, virology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	2.9K
2	Biochemistry	5	5	1.2K
3	Health Sciences	4	4	130
4	Natural Sciences	4	4	1.1K
5	Engineering	1	1	155

I. B. R. Duncan

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Rational Design of Peptide-Based HIV Proteinase Inhibitors Noel A. Roberts, Joseph A. Martin, Derek Kinchington, Science ImmunologyAntiviral DrugMedicinal ChemistryPeptide DerivativesRational Design	1990	922
Control of distal antennal identity and tarsal development in Drosophila by spineless-aristapedia, a homolog of the mammalian dioxin receptor Dianne Duncan, E. A. Burgess, I. B. R. Duncan Genes & Development Distal Antennal IdentityGeneticsDistal AntennaMolecular GeneticsCytoskeleton	1998	280
Characterization of human immunodeficiency virus type 1 mutantswith decreased sensitivity to proteinase inhibitor Ro 31-8959 Helmut Jacobsen, Kaya Yasargil, Dean L. Winslow, Virology Viral ReplicationHuman RetrovirusPathogenesisImmunologyAntiviral Response	1995	190
Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase Jane Craig, I. B. R. Duncan, D. J. Hockley, Antiviral Research Human Immunodeficiency VirusBiochemistryMedicineHuman RetrovirusAntiviral Drug Development	1991	187
Safety and activity of saquinavir in HIV infection V. S. Kitchen, Charlotte Skinner, Koya Ariyoshi, The Lancet Hiv InfectionAntiviral TherapyVirologyAntiviral DrugHiv	1995	187
In Vivo Resistance to a Human Immunodeficiency Virus Type 1 Proteinase Inhibitor: Mutations, Kinetics, and Frequencies Helmut Jacobsen, Markus Hänggi, Michael Ott, The Journal of Infectious Diseases	1996	172
Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro Armin Bender, Hagen von Briesen, J. Kreuter, Antimicrobial Agents and Chemotherapy NanoparticlesEngineeringImmunologyBiomedical EngineeringAntiviral Drug	1996	155
Contributions to Microbiology and Immunology I. B. R. Duncan Europe PMC (PubMed Central) Medical MicrobiologyPathogenic MicrobiologyMicrobial DiseaseMicrobiologyHost-microbe Interaction	1978	146
Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1) D. J. BUSHNELL, I. B. R. Duncan, Stephen J. Dunsdon, Journal of Medicinal Chemistry Bioorganic ChemistryAntiviral DrugHuman Immunodeficiency VirusChemical BiologyPharmaceutical Chemistry	1990	71
Isolation and Characterization of Temperature-Sensitive Mutants of Vesicular Stomatitis Virus, New Jersey Serotype C. R. Pringle, I. B. R. Duncan, Mary C. Stevenson Journal of Virology Virus StructureViral ReplicationMolecular VirologyPathogenesisTemperature-sensitive Mutants	1971	68

Page 1